Caribou Biosciences (CRBU) Cash from Operations (2020 - 2026)
Caribou Biosciences (CRBU) reported Cash from Operations of 27000000.0 for Q1 2026, up 26.48% year-over-year from 21347147.47 in Q1 2025, and down 29.61% quarter-over-quarter from 20832000.0 in Q4 2025.
Caribou Biosciences (CRBU) Cash from Operations (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Cash from Operations data on file, last reported at 27000000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 27000000.0, up 26.48% year-over-year; the trailing twelve-month figure through Mar 2026 was 101275000.0 (up 26.46% YoY), and the FY2025 annual result was 111000000.0, up 19.68% from the prior year.
- Cash from Operations fell to 27000000.0 in Q1 2026 per CRBU's latest filing, from 20832000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 15185000.0 in Q2 2023 and troughed at 37203000.0 in Q1 2024.
- A 5-year average of 27085705.88 and a median of 27000000.0 in 2026 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations tumbled 206.7% in 2022, then surged 41.27% in 2025.
- A 5-year view of Cash from Operations shows it stood at 25044000.0 in 2022, then increased by 14.63% to 21379000.0 in 2023, then slumped by 65.91% to 35470000.0 in 2024, then surged by 41.27% to 20832000.0 in 2025, then decreased by 29.61% to 27000000.0 in 2026.
- Business Quant data shows CRBU's Cash from Operations at 27000000.0 in Q1 2026, 20832000.0 in Q4 2025, and 25185000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | -27.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.00 Mn |
| Mar 31, 2026 | -27.00 Mn |
| Dec 31, 2025 | -20.83 Mn |
| Dec 31, 2025 | -20.83 Mn |
| Sep 30, 2025 | -25.19 Mn |
| Sep 30, 2025 | -25.19 Mn |
| Jun 30, 2025 | -28.26 Mn |
| Jun 30, 2025 | -28.26 Mn |
| Mar 31, 2025 | -36.73 Mn |
| Mar 31, 2025 | -36.73 Mn |
| Dec 31, 2024 | -35.47 Mn |
| Dec 31, 2024 | -35.47 Mn |
| Sep 30, 2024 | -32.66 Mn |
| Sep 30, 2024 | -32.66 Mn |
| Jun 30, 2024 | -32.87 Mn |
| Jun 30, 2024 | -32.87 Mn |
| Mar 31, 2024 | -37.20 Mn |
| Mar 31, 2024 | -37.20 Mn |
| Dec 31, 2023 | -21.38 Mn |
| Dec 31, 2023 | -21.38 Mn |